By Vijaykumar S SinghaviThe pandemic has set in many a new normal to follow. This has been particularly true of the business world, which has been advertently or otherwise forced…
By Nancy Lapid The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to…
By Michael Erman and Deena Beasley NEW YORK -Pfizer Inc on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and…
By Michael Erman and Julie Steenhuysen NEW YORK, – Moderna Inc could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as…
By Deena Beasley Roche Holding AG, still months away from seeking regulatory approval of its experimental Alzheimer’s drug, is already taking aim at rival Biogen Inc’s Aduhelm, saying that its…
AP Photo/Lynne Sladky Pfizer asked U.S. regulators Tuesday to allow boosters of its COVID-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of…
By Manas Mishra and Michael Erman The U.S. Food and Drug Administration on Friday authorized the Pfizer Inc and BioNTech SE coronavirus vaccine for children aged 5 to 11 years,…
By Carl O’Donnell An estimated 30 million to 50 million doses of Johnson & Johnson’s COVID-19 vaccine made early this year sits idle in Emergent BioSolutions Inc’s plant in Baltimore…
An expert panel on Tuesday will vote on whether to recommend the U.S. Food and Drug Administration authorize the Pfizer Inc and BioNTech COVID-19 vaccine for children ages 5 to…
By Ankur Banerjee and Michael Erman The U.S. Food and Drug Administration on Wednesday authorized booster doses of the COVID-19 vaccines from Moderna Inc and Johnson & Johnson, and said…
